Exact Mass: 592.3012
Exact Mass Matches: 592.3012
Found 145 metabolites which its exact mass value is equals to given mass value 592.3012
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Hexobendine
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-{[5,7-dihydroxy-2,2-dimethyl-6-butanoyl-8-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-acetyl-2,5-cyclohexadien-1-one|yungensin F
2-{[5,7-dihydroxy-2,2-dimethyl-8-butanoyl-6-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-acetyl-2,5-cyclohexadien-1-one|yungensin A
[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] dodecanoate
[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] dodecanoate [IIN-based: Match]
[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] dodecanoate [IIN-based on: CCMSLIB00000848201]
[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] dodecanoate [IIN-based on: CCMSLIB00000848200]
Asp Phe Arg Arg
Asp Arg Phe Arg
Asp Arg Arg Phe
Phe Asp Arg Arg
Phe Ile Gln Trp
Phe Ile Trp Gln
Phe Leu Gln Trp
Phe Leu Trp Gln
Phe Gln Ile Trp
Phe Gln Leu Trp
Phe Gln Trp Ile
Phe Gln Trp Leu
Phe Arg Asp Arg
Phe Arg Arg Asp
Phe Trp Ile Gln
Phe Trp Leu Gln
Phe Trp Gln Ile
Phe Trp Gln Leu
Ile Phe Gln Trp
Ile Phe Trp Gln
Ile Gln Phe Trp
Ile Gln Trp Phe
Ile Trp Phe Gln
Ile Trp Gln Phe
Lys Pro Trp Tyr
Lys Pro Tyr Trp
Lys Trp Pro Tyr
Lys Trp Tyr Pro
Lys Tyr Pro Trp
Lys Tyr Trp Pro
Leu Phe Gln Trp
Leu Phe Trp Gln
Leu Gln Phe Trp
Leu Gln Trp Phe
Leu Trp Phe Gln
Leu Trp Gln Phe
Met Met Arg Arg
Met Arg Met Arg
Met Arg Arg Met
Pro Lys Trp Tyr
Pro Lys Tyr Trp
Pro Trp Lys Tyr
Pro Trp Tyr Lys
Pro Tyr Lys Trp
Pro Tyr Trp Lys
Gln Phe Ile Trp
Gln Phe Leu Trp
Gln Phe Trp Ile
Gln Phe Trp Leu
Gln Ile Phe Trp
Gln Ile Trp Phe
Gln Leu Phe Trp
Gln Leu Trp Phe
Gln Trp Phe Ile
Gln Trp Phe Leu
Gln Trp Ile Phe
Gln Trp Leu Phe
Arg Asp Phe Arg
Arg Asp Arg Phe
Arg Phe Asp Arg
Arg Phe Arg Asp
Arg Met Met Arg
Arg Met Arg Met
Arg Arg Asp Phe
Arg Arg Phe Asp
Arg Arg Met Met
Trp Phe Ile Gln
Trp Phe Leu Gln
Trp Phe Gln Ile
Trp Phe Gln Leu
Trp Ile Phe Gln
Trp Ile Gln Phe
Trp Lys Pro Tyr
Trp Lys Tyr Pro
Trp Leu Phe Gln
Trp Leu Gln Phe
Trp Pro Lys Tyr
Trp Pro Tyr Lys
Trp Gln Phe Ile
Trp Gln Phe Leu
Trp Gln Ile Phe
Trp Gln Leu Phe
Trp Tyr Lys Pro
Trp Tyr Pro Lys
Tyr Lys Pro Trp
Tyr Lys Trp Pro
Tyr Pro Lys Trp
Tyr Pro Trp Lys
Tyr Trp Lys Pro
Tyr Trp Pro Lys
benzene-1,3-dicarboxylic acid,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,2,2,4-trimethylpentane-1,3-diol
4-Methylumbelliferyl 6-thio-Palmitate-β-D-Glucopyranoside
hexobendine
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-2-(acetyloxymethyl)-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] dodecanoate
5alpha-cinnamoyloxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN011414","Ingredient_name": "5alpha-cinnamoyloxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene","Alias": "5\u03b1-cinnamoyloxy-9\u03b1,10\u03b2,13\u03b1-triacetoxytaxa-4(20),11-diene","Ingredient_formula": "C35H44O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30787;3717","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}